Background. The objective of this systematic review and meta-analysis was to estimate the proportions of individuals infected with
Campylobacter,
Escherichia,
Salmonella,
Shigella, or
Yersinia who develop reactive arthritis.
Methods. A systematic review was conducted, encompassing English-language articles published before January 2024, sourced from the Embase, PubMed, Scopus, and Web of Science databases. This review included observational studies that reported the occurrence of reactive arthritis (ReA) among patients with
Campylobacter,
Escherichia,
Salmonella,
Shigella, or
Yersinia infections. Data extraction was carried out independently by two reviewers. Subsequently, a random-effects meta-analysis was performed, with heterogeneity assessed using the I
2 value. Additionally, meta-regression was employed to investigate the potential influence of study-level variables on the observed heterogeneity.
Results. A total of 87 studies were identified; 23 reported on ReA development after
Campylobacter infection, 7 reported on ReA after
Escherichia infection, 30 reported ReA onset after salmonellosis, 14 reported ReA after shigellosis, and 13 reported ReA after
Yersinia infection. The proportion of
Campylobacter patients who developed ReA was 0.03 (95% CI [0.01, 0.06], I
2 = 97.62%); the proportion of
Escherichia patients who developed ReA was 0.01 (95% CI [0.00, 0.06], I
2 = 92.78%); the proportion of
Salmonella patients was 0.04 (95% CI [0.02, 0.08], I
2 = 97.67%); the proportion of
Shigella patients was 0.01 (95% CI [0.01, 0.03], I
2 = 90.64%); and the proportion of
Yersinia patients who developed ReA was 0.05 (95% CI [0.02, 0.13], I
2 = 96%).
Conclusion. A significant proportion of
Salmonella,
Shigella, and
Yersinia cases resulted in ReA. Nonetheless, it is important to interpret the findings cautiously due to the substantial heterogeneity observed between studies.
Full article